Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01510288 |
Recruitment Status
:
Terminated
(The study was terminated because Cell Genesys stopped all activities for GVAX.)
First Posted
: January 16, 2012
Last Update Posted
: January 16, 2012
|
Sponsor:
VU University Medical Center
Collaborators:
Cell Genesys
Medarex
Information provided by (Responsible Party):
A.J.M. van den Eertwegh, VU University Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | December 2007 |
Actual Study Completion Date : | November 2011 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):